Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06607523 · ClinicalTrials.gov registry record · NA
The Gut-Brain Axis During Neurorehabilitation; Prebiotic Treatment to Alter the Gut Microbiome and Neurologic Symptoms
A NA study of Brain Injuries, sponsored by The University of Texas Medical Branch, Galveston.
- Recruiting
- Registry status
- NA
- Development phase
- 130
- Enrollment target
- 1
- Study location
NCT06607523: Recruiting NA study of Brain Injuries, sponsored by The University of Texas Medical Branch, Galveston.
NCT06607523 is a NA study of Brain Injuries that is actively recruiting participants, run by The University of Texas Medical Branch, Galveston. The registered enrollment target is 130 participants, below the 325-participant average among 22 other Brain Injuries trials with a reported enrollment target (60% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06607523, a NA study of Brain Injuries, is actively recruiting participants, sponsored by The University of Texas Medical Branch, Galveston.
- RECRUITING
- Registry status
- NA
- Development phase
- 130 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this study is to characterize the microbiome of patients undergoing post-acute residential neurorehabilitation compared to community controls and to determine if a dietary fiber, Inulin, can create a shift in the microbiome leading to changes in fatigue and cognition.
Primary Outcome
Metagenomic analysis using a custom PCR array will be performed on stool samples to identify associated changes in microbiome absolute abundance at the genus and species level.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Inulin
Study Locations (1)
Texas
- University of Texas Medical Branch - Galveston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2025-03-06 |
| Est. Completion | 2028-10-01 |
| Phase | NA |
What NCT06607523 shows while recruiting
NCT06607523 is an interventional study that assigns participants to a tested intervention. The registered 130 participants enrollment target is mid-sized for trials with a published cap, below the 325-participant average among 22 other Brain Injuries trials with a reported enrollment target (60% lower).
The record links to 1 condition, with Brain Injuries appearing as the primary indexed condition, and to 1 intervention - of which Inulin is the first listed.
NCT06607523 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06607523 about?
NCT06607523 is a clinical study titled "The Gut-Brain Axis During Neurorehabilitation; Prebiotic Treatment to Alter the Gut Microbiome and Neurologic Symptoms". The aim of this study is to characterize the microbiome of patients undergoing post-acute residential neurorehabilitation compared to community controls and to determine if a dietary fiber, Inulin, can create a shift in the microbiome leading to changes in fatigue and cognition.
What is the current status of trial NCT06607523?
This trial is currently recruiting. It is a NA study. The enrollment target is 130 participants. The study started on 2025-03-06. Estimated completion is 2028-10-01.
What conditions does trial NCT06607523 study?
This clinical trial studies the following conditions: Brain Injuries.
What interventions are being tested in trial NCT06607523?
The interventions under investigation include: Inulin (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06607523?
This trial is sponsored by The University of Texas Medical Branch, Galveston, which has 203 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06607523 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Brain Injuries
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06607523's enrollment target sits among peer trials
130 11th of 22 higher than 12 of 22 other Brain Injuries trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Brain Injuries trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Remotely Supervised tDCS+ for Complex Attention in mTBI (Cognetric)
RECRUITING · NA
-
Biomarker Role in Assessing Imaging Needs for Mild Cranial Trauma
RECRUITING · NA
-
Mobile Health Self-Management and Support System for Chronic and Complex Health Conditions
RECRUITING · NA
-
The HOME Study (Healthy Options Made Easy): Telehealth Nutrition Sessions for People Living With Brain Injury
RECRUITING · NA
-
Animal Assisted Therapy After Pediatric Brain Injury: Mediators and Moderators of Treatment Response.
RECRUITING · NA
-
Multimodal Monitoring of Cerebral Autoregulation After Pediatric Brain Injury
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01492036 · 130 participants
Long-Term Follow-Up of Recipient of Gene Transfer Research
- NCT01631617 · 130 participants · Phase 2
Effects of Treatments on Atopic Dermatitis
- NCT02368041 · 130 participants
Utility of Thenar Near Infrared Spectroscopy (NIRS) in Pediatric Patients With Heart Failure
- NCT02604277 · 130 participants · NA
Suicidal Behavior in Patients Diagnosed With Bipolar Disorder
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI